Director at TG Therapeutics (TGTX) granted 8,325 stock tracking units
Rhea-AI Filing Summary
TG Therapeutics director Laurence N. Charney received a grant of 8,325 Stock Tracking Units on June 11, 2026. These units were awarded as compensation and carry no exercise price.
Each Stock Tracking Unit represents a contingent right, at the discretion of the plan committee, to receive either one share of TG Therapeutics common stock or a cash payment equal to the fair market value of one share. This payment or share delivery is scheduled no later than 30 days after the first anniversary of the grant date, provided Charney remains in continuous service through that vesting date.
Following this award, Charney holds 8,325 Stock Tracking Units directly, each tied to an equivalent number of underlying common shares. The transaction does not involve any open-market buying or selling, and reflects a routine equity-based incentive grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Charney Laurence N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Tracking Unit | 8,325 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Tracking Unit — 8,325 shares (Direct)
Footnotes (2)
- F1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.
- F2. Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant.
Key Figures
Stock Tracking Units granted: 8,325 units
Underlying common shares: 8,325 shares
Exercise price per unit: $0.00
+2 more
5 metrics
Stock Tracking Units granted
8,325 units
Grant to director on June 11, 2026
Underlying common shares
8,325 shares
Each unit tied to one common share
Exercise price per unit
$0.00
Grant/award acquisition, no exercise cost
Settlement deadline
30 days after first anniversary
Settlement in stock or cash post-vesting
Total units after transaction
8,325 units
Director’s direct holdings following grant
Key Terms
Stock Tracking Unit, contingent right, fair market value, Vesting Date, +1 more
5 terms
Stock Tracking Unit financial
"Each stock tracking unit ("STU") represents a contingent right to receive either..."
contingent right financial
"represents a contingent right to receive either (i) one share... or (ii) a cash payment..."
fair market value financial
"a cash payment equal to the fair market value of one share of the Issuer's common stock"
The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.
Vesting Date financial
"Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date..."
continuous service financial
"Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date..."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did TG Therapeutics (TGTX) director Laurence N. Charney report in this Form 4?
Laurence N. Charney reported receiving 8,325 Stock Tracking Units as a grant. The award was made on June 11, 2026, carries no exercise price, and represents equity-based compensation rather than an open-market share purchase or sale.
How many Stock Tracking Units were granted to the TG Therapeutics (TGTX) director?
The director received 8,325 Stock Tracking Units. Each unit is linked to an equivalent number of underlying TG Therapeutics common shares, giving the holder a potential claim on 8,325 shares or the cash value of those shares at settlement.
What does each Stock Tracking Unit in the TG Therapeutics (TGTX) grant represent?
Each Stock Tracking Unit represents a contingent right to value equal to one common share. At the plan committee’s discretion, this can be settled in either one share of TG Therapeutics common stock or a cash payment equal to that share’s fair market value.
When do the TG Therapeutics (TGTX) Stock Tracking Units granted to the director vest and pay out?
The Stock Tracking Units vest on the first anniversary of the grant date. Provided the director remains in continuous service through that vesting date, settlement in shares or cash must occur no later than 30 days after the first anniversary of the grant.
How many TG Therapeutics (TGTX) Stock Tracking Units does the director hold after this grant?
After the transaction, the director holds 8,325 Stock Tracking Units directly. This equals the full amount granted in the filing, and these units are tied to an equivalent number of underlying TG Therapeutics common shares for future settlement.